| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |
1 Tsinghua Institute of Genome Research, Department of Biological Sciences and Biotechnology and Institute of Biomedicine, Tsinghua University, and 2 Institute of Basic Medical Sciences, Peking Union Medical College, Beijing, China; and 3 Department of Pathology, Yale University School of Medicine, New Haven, Connecticut
Receptor protein tyrosine kinases (RPTKs) play important roles in the regulation of a variety of cellular processes including cell migration, proliferation, and protection from apoptosis. Here, we report the identification and characterization of a novel RPTK-like molecule that has a critical role in induction of tumorigenesis and metastasis and is termed Novel Oncogene with Kinase-domain (NOK). NOK contains a putative single transmembrane domain and a conserved intracellular tyrosine kinase domain that shares homology with members of the platelet-derived growth factor/fibroblast growth factor receptor superfamily. NOK was exclusively located in the cytoplasm. NOK mRNAs were detected in limited human organs and expressed with the highest abundance in the prostate. A variety of tumor cells also expressed the NOK mRNAs. We demonstrated that NIH3T3 and BaF3 cells could be strongly transformed by the expression of the NOK gene as examined by colony formation experiment. In addition, BaF3 cells with the stable expression of NOK induced rapid tumorigenesis in nude mice. Interestingly, these NOK-expressing tumor cells could promptly invade and spread into various distinct organs and form metastatic foci, eventually leading to the rapid death of these animals. Moreover, molecular mechanism studies indicated that NOK could concomitantly activate both MAP kinase and phosphatidylinositol 3'-kinases (PI3K) pathways in stable BaF3 cells. Thus, our results both in vitro and in vivo suggest that NOK is a novel oncogene with the capacity of promoting cell transformation, tumorigenesis, and metastasis.
This article has been cited by other articles:
![]() |
S. D'Aniello, M. Irimia, I. Maeso, J. Pascual-Anaya, S. Jimenez-Delgado, S. Bertrand, and J. Garcia-Fernandez Gene Expansion and Retention Leads to a Diverse Tyrosine Kinase Superfamily in Amphioxus Mol. Biol. Evol., September 1, 2008; 25(9): 1841 - 1854. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kimura, T. Yamamoto, J. Zhang, K. Itoh, M. Kyo, T. Kamiya, H. Aburatani, F. Katsuoka, H. Kurokawa, T. Tanaka, et al. Molecular Basis Distinguishing the DNA Binding Profile of Nrf2-Maf Heterodimer from That of Maf Homodimer J. Biol. Chem., November 16, 2007; 282(46): 33681 - 33690. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. L. Conway-Campbell, J. W. Wooh, A. J. Brooks, D. Gordon, R. J. Brown, A. M. Lichanska, H. S. Chin, C. L. Barton, G. M. Boyle, P. G. Parsons, et al. Nuclear targeting of the growth hormone receptor results in dysregulation of cell proliferation and tumorigenesis PNAS, August 14, 2007; 104(33): 13331 - 13336. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Chen, Y.-H. Li, X.-P. Chen, L.-M. Gong, S.-P. Zhang, Z.-J. Chang, X.-F. Zhang, X.-Y. Fu, and L. Liu Point Mutation at Single Tyrosine Residue of Novel Oncogene NOK Abrogates Tumorigenesis in Nude Mice Cancer Res., December 1, 2005; 65(23): 10838 - 10846. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |